KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Other financing activities (2016 - 2025)

Encompass Health (EHC) has disclosed Other financing activities for 17 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities rose 101.31% year-over-year to $1.8 million, compared with a TTM value of $1.8 million through Dec 2025, down 10.0%, and an annual FY2025 reading of $1.8 million, down 10.0% over the prior year.
  • Other financing activities was $1.8 million for Q4 2025 at Encompass Health, down from $7.6 million in the prior quarter.
  • Across five years, Other financing activities topped out at $564.7 million in Q2 2022 and bottomed at -$514.7 million in Q3 2022.
  • Average Other financing activities over 5 years is $27.2 million, with a median of $5.1 million recorded in 2022.
  • Peak annual rise in Other financing activities hit 459900.0% in 2022, while the deepest fall reached 1321.82% in 2022.
  • Year by year, Other financing activities stood at $100000.0 in 2021, then surged by 459900.0% to $460.0 million in 2022, then tumbled by 111.65% to -$53.6 million in 2023, then tumbled by 156.9% to -$137.7 million in 2024, then skyrocketed by 101.31% to $1.8 million in 2025.
  • Business Quant data shows Other financing activities for EHC at $1.8 million in Q4 2025, $7.6 million in Q2 2025, and -$7.6 million in Q1 2025.